AnalyzeDirect

Abrogation of Oncogenic RAS Signaling by a RAS (ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint Blockade

Xing Wei de Natale et al. Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint Blockade Cancer Discovery. Publication Date February 11, 2026 How Analyze was Used “Serial lung images were reconstructed, and tumor volumes were subsequently analyzed using Analyze 14.0 (AnalyzeDirect). Randomization was performed when…